Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-11-16
2009-08-18
Landsman, Robert (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C530S387100
Reexamination Certificate
active
07575878
ABSTRACT:
The invention relates to a new type of leptin receptor antagonist, which is able to prevent leptin signaling without preventing the binding of leptin to the leptin binding domain. More specifically, the invention relates to the use of a part of the leptin receptor to prevent the leptin-dependent activation of the receptor, and by this the leptin-induced signaling.
REFERENCES:
patent: 5521066 (1996-05-01), Menzel et al.
patent: 5686281 (1997-11-01), Roberts
patent: 5716622 (1998-02-01), Darnell et al.
patent: 5744314 (1998-04-01), Menzel et al.
patent: 5776689 (1998-07-01), Karin et al.
patent: 5843697 (1998-12-01), Pestka et al.
patent: 5885779 (1999-03-01), Sadowski et al.
patent: 5972621 (1999-10-01), Tartaglia et al.
patent: 6001816 (1999-12-01), Morsy et al.
patent: 6270964 (2001-08-01), Michnick et al.
patent: 6294330 (2001-09-01), Michnick et al.
patent: 6303319 (2001-10-01), Rickles
patent: 6342345 (2002-01-01), Blau et al.
patent: 6380363 (2002-04-01), Tartaglia et al.
patent: 6734006 (2004-05-01), Xiao et al.
patent: 2001/0023062 (2001-09-01), Ostade et al.
patent: 2004/0202652 (2004-10-01), Karsenty et al.
patent: 0 646 644 (1995-04-01), None
patent: WO 96/05309 (1996-02-01), None
patent: WO 97/00319 (1997-01-01), None
patent: WO 97/20933 (1997-06-01), None
patent: WO97/26335 (1997-07-01), None
patent: WO 97/31113 (1997-08-01), None
patent: WO 97/46585 (1997-12-01), None
patent: WO 98/02542 (1998-01-01), None
patent: WO 98/12224 (1998-03-01), None
patent: WO 98/20158 (1998-05-01), None
patent: WO 98/34120 (1998-08-01), None
patent: WO 98/44350 (1998-10-01), None
patent: WO 99/03974 (1999-01-01), None
patent: WO 99/40946 (1999-08-01), None
patent: WO 00/06722 (2000-02-01), None
patent: WO 00 07014 (2000-02-01), None
patent: WO 00/07038 (2000-02-01), None
patent: WO 02/40543 (2002-05-01), None
patent: WO 02/062833 (2002-08-01), None
Banks et al., Activation of Downstream Signals by the Long Form of the Leptin Receptor, Journal of Biological Chemistry, May 12, 2000, pp. 14563-14572, vol. 275, No. 19, U.S.A.
Baumann et al., Proc. Natl. Acad. Sci. USA, 1996, pp. 8374-8378, vol. 93.
Beattie, et al., Obesity and Hyperleptinemia in Metallothionein (-I and -II) Null Mice, Proceedings of the National Academy of Sciences of USA, Jan. 1998, pp. 358-363, vol. 95.
Bjorbaek et al., Identification of SOCS-3 as a Potential Mediator of Central Leptin Resistance, Molecular Cell, Mar. 1998, pp. 619-625, vol. 1, No. 4.
Bjorbaek et al., The Role of SOCS-3 in Leptin Signaling and Leptin Resistance, The Journal of Biological Chemistry, Oct. 15, 1999, pp. 30059-30065, vol. 274, No. 42.
Bonnefoy-Berard et al., “Vav: Function and Regulation in Hematopoietic Cell Signaling,” 14 Stem Cells 250-68 (1996).
Campfield et al., Science, 1998, pp. 1383-1389, vol. 280.
Carpenter et al., Proc Natl Acad Sci USA, 1998, pp. 6061-6066, vol. 95.
Colas et al., The impact of two-hybrid and related methods on biotechnology, Trends in Biotechnology, Aug. 1998, pp. 355-363, vol. 16.
Daly et al., Recognition of human colon cancer by T cells transduced with a chimeric receptor gene, Cancer Gene Therapy, 2000, pp. 284-291, vol. 7, No. 2.
David et al., J. Biol. Chem. 1996, pp. 4585-4588, vol. 271.
Dusetti et al., Structural organization of the gene encoding the rat pancreatitis-associated protein, Jul. 5, 1993, pp. 14470-14475, vol. 268.
Dusetti et al., The pancreatitis-associated protein I promoter allows targeting to the pancreas of a foreign gene whose expression is up-regulated during pancreatic inflammation, Feb 28, 1997, pp. 5800-5804.
Eyckerman et al., Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line, Eur. Cytokine Netw, Dec. 1999, pp. 549-556, vol. 10, No. 4.
Eyckerman et al., Design and application of a cytokine-receptor-based interaction trap, Nature Cell Biology, Dec. 2001, pp. 1114-1119, vol. 3, EBSCO Publishing.
Fields et al., The two-hybrid system: an assay for protein-protein interactions, Trends in Genetics, Aug. 1994, pp. 286-292, vol. 10, No. 8.
Ghilardi et al., Proc. Natl. Acad. Sci. USA, 1996, pp. 6231-6235, vol. 93.
Gisselbrecht, Sylvie, The CIS/SOCS proteins: a family of cytokine-inducible regulators of signaling, 10(4) European Cytokine Network 463-470 (Dec. 1999), retrieved from <URL:http://www.john-libbey-eurotest.fr/articles/ccn/10/4/463-70/> Jul. 12, 2001.
Grasso et al., Endocrinol, 1997, pp. 1413-1418, vol. 138.
Ihle et al., Jaks and Stats in signaling by the cytokine receptor superfamily, Trends Genet., Feb. 1995, pp. 69-74, vol. 11, No. 2.
Iyengar, FASEB J., 1993, pp. 768-775, vol. 7.
Lee et al., Abnormal splicing of the leptin receptor in diabetic mice, Nature, Feb. 15, 1996, pp. 632-635, vol. 379.
Medici et al., The EMBO Journal, 1997, pp. 7241-7249, vol. 16, No. 24.
Mercer et al., Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization, FEBS Letters, 1996, pp. 113-116, vol. 387.
Montoye et al., Analysis of leptin signalling in hematopoietic cells using an adapted MAPPIT strategy, FEBS Letters, 2006, pp. 3301-3307, vol. 580.
Montoye et al., In Press, A systematic scan of interactions with tyrosine motifs in the erythropoietin receptor using a mammalian two-hybrid approach.
Nakashima et al., FEBS, 1997, pp. 79-82, vol. 403.
Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction, Chapter 14: Computational Complexity Protein Structure Prediction, and the Levinthal Paradox, Mar. 2, 1994, pp. 492-495.
Okuda et al., Ann N Y Acad Sci., 1999, pp. 305-312, vol. 872.
Osborne et al., The Yeast Tribrid System—Genetic Detectiion of trans-phosphorylated ITAM-SH2-Interactions, Biotechnology, Dec. 13, 1995, pp. 1474-1478, vol. 13.
Overton et al., Current Biology, 2000, pp. 341-344, vol. 10, No. 6.
Ray et al., J. Clin. Invest. 1996, pp. 1852-1859, vol. 97.
Rohner-Jearnrenaud et al., The New Eng. J. Med., 1996, pp. 324-325, vol 334.
Saitoh et al., Identification of Important Regions in the Cytoplasmic Justamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-beta, The Journal of Biological Chemistry, Feb. 2, 1996, pp. 2769-2775, vol. 271, No. 5.
Shores et al., Curr Opin Immunol., 1997, pp. 380-389, vol. 9, No. 3.
Stoffel et al., Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decision in vivo, Proc. Natl. Acad. Sci. Jan. 1999, pp. 698-702, vol. 96.
Tartaglia et al., Identification and Expression Cloning of a Leptin Receptor, OB-R, Cell, Dec. 29, 1995, pp. 1263-1271, vol. 83.
Vaisse et al., Leptin Activation of Stat3 in the Hypothalamus of Wild-Type and ob/ob Mice but not db/db Mice, Nature Genetics, Sep. 14, 1996, pp. 95-97, vol. 14.
Verploegen et al., FEBS Letters, 1997, pp. 237-240, vol. 405.
Waelput et al., Analysis of Signal Transduction via the Leptin Receptor, International Journal of Obesity, Aug. 1998, pp. S99, vol. 22, No. Suppl. 3.
Wells, Additivity of Mutational Effects in Proteins, Biochemistry, Sep. 18, 1990, pp. 8509-8517, vol. 29, No. 37.
Zabeau et al., The ins and outs of leptin receptor activation, FEBS Letters, 2003, pp. 45-50, vol. 546.
Fazeli et al., Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation, Journal of Immunological Methods, 2006, pp. 190-200, vol. 312.
Tavernier Jan
Zabeau Lennart
Chandra Gyan
Landsman Robert
TraskBritt
Universiteit Gent
VIB vzw
LandOfFree
Methods of inhibiting leptin-induced signaling with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting leptin-induced signaling with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting leptin-induced signaling with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4081006